Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Plain language summary of the VOLTAIRE-RA in patients with moderate-to-severe rheumatoid arthritis.
Journal: Immunotherapy
Published: September 06, 2022
Similar efficacy, safety and immunogenicity of adalimumab biosimilar BI 695501 and Humira reference product in patients with moderately to severely active rheumatoid arthritis: results from the phase III randomised VOLTAIRE-RA equivalence study.
Journal: Annals of the rheumatic diseases
Published: August 17, 2017
Showing 1-4 of 4
Last Updated: 09/26/2026